Core Insights - Analysts project Bausch + Lomb (BLCO) will report quarterly earnings of $0.35 per share, reflecting a 40% year-over-year increase [1] - Revenue is expected to reach $1.38 billion, marking an 8.1% increase from the same quarter last year [1] - The consensus EPS estimate has remained unchanged over the past 30 days, indicating analysts' reassessment of projections [1] Revenue Estimates - 'Revenues- Vision Care' are projected to be $780.35 million, representing a year-over-year change of +7.9% [4] - 'Revenues- Pharmaceuticals' are estimated at $355.40 million, indicating a +9% change from the previous year [4] - 'Revenues- Product sales' are expected to total $1.37 billion, reflecting a +7.6% year-over-year change [4] Other Revenue Metrics - 'Revenues- Other revenues' are anticipated to reach $5.00 million [5] - 'Revenues- Surgical' are projected at $248.04 million, suggesting a +7.4% year-over-year increase [5] - Bausch + Lomb shares have decreased by -0.8% over the past month, compared to the Zacks S&P 500 composite's -1.7% [5]
Ahead of Bausch + Lomb (BLCO) Q4 Earnings: Get Ready With Wall Street Estimates for Key Metrics